Signal Transduction and Targeted Therapy Impact Factor, Quartile, Indexing, Ranking

Signal Transduction and Targeted Therapy Impact Factor, Indexing, Ranking

Signal Transduction and Targeted Therapy (STTr) is a scholarly journal dedicated to publishing research in the field of Biochemistry, Genetics and Molecular Biology, and Published by Springer. The Print-ISSN to Signal Transduction and Targeted Therapy is 2095-9907 and its abbreviation is Signal Transduct Target Ther.


Signal Transduction and Targeted Therapy Aim and Scope

Signal Transduction and Targeted Therapy is an international, peer-reviewed, open-access journal that publishes original research articles and review articles related to all aspects of signal transduction in physiological and pathological processes, as well as signal transduction-targeted therapeutics in the form of biological agents and small molecular drugs used to treat human diseases such as cancer, autoimmune disorders, and others. This journal focuses on cutting-edge advances both experimentally and clinically.


Signal Transduction and Targeted Therapy Details


Journal title Signal Transduction and Targeted Therapy (STTr)
Abbreviation Signal Transduct Target Ther
Print ISSN 2095-9907
Online ISSN 2059-3635
Publisher Name Springer
Editor-in-chief Prof. Carlo M. Croce, Institute of Genetics, The Ohio State University, Columbus, Ohio, USA
Subject Category Biochemistry, Genetics and Molecular Biology
Access type Logo of open access journals Open Access
Impact Factor 37.2
SJR 6.630
SNIP 4.133
Ranking 103
CiteScore 31.5
H-Index 83
Quartile Q1
Status 🟢 Active
Abstracting and Indexing
Impact Factor List 2024

Who we are? Clarification: Journals Insights - Your Open Access Ally
F T L W E